Keywords: biogen, begins, long-term, avonex, study, inc, initiated

Biogen begins long-term Avonex study

Article | 19 October 2000

Print This

Biogen Inc has initiated a new five-year trial to investigate thelong-term effects of its multiple sclerosis drug Avonex (interferon beta-1 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in